The Readout Loud

336 Episodes

1. 214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

   Published: 6/23/2022
2. 213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

   Published: 6/16/2022
3. 212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

   Published: 6/9/2022
4. 211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

   Published: 6/2/2022
5. 210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

   Published: 5/26/2022
6. Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

   Published: 5/19/2022
7. Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise

   Published: 5/12/2022
8. Episode 207: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner

   Published: 5/5/2022
9. Episode 206: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum

   Published: 4/28/2022
10. Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices

    Published: 4/21/2022
11. Episode 204: Leana Wen on the pandemic's new normal and whether Twitter is real life

    Published: 4/14/2022
12. Episode 203: What's next for Roche, a debate over second boosters, & Vertex's recent success

    Published: 4/7/2022
13. Introducing: Color Code

    Published: 3/31/2022
14. Episode 202: Helen Branswell on the pandemic, plus the next FDA debate & the perks of being a CEO

    Published: 3/24/2022
15. Episode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas

    Published: 3/17/2022
16. Episode 200: Gilead's growing pains, Covid's origins, & Theranos as prestige TV

    Published: 3/10/2022
17. Episode 199: Biden's plans for Covid pills, the latest vaccine data, & fighting about CRISPR

    Published: 3/3/2022
18. Episode 198: Medical racism, new Covid vaccines, & the resilience of Regeneron

    Published: 2/24/2022
19. Episode 197: Robert Califf's FDA return, the future of CRISPR, & another vaccine delay

    Published: 2/17/2022
20. Episode 196: Eric Lander's resignation, FDA's about-face, & Pfizer's lucrative pandemic

    Published: 2/10/2022